1 year ago

Precision Medicine Market share of over 30% dominated by Oncology applications

Get more details @ Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics.

Europe precision

Europe precision medicine market size, by application, 2013 - 2023 (USD Million) Browse key industry insights spread across 94 pages with 85 market data tables & 62 figures & charts from the report, “Precision Medicine Market Size By Technology (Big Data Analytics, Gene Sequencing, Drug Discovery, Bioinformatics, Companion Diagnostics), By Application (Oncology, CNS, Immunology, Respiratory), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Scandinavia, Italy, Japan, China, India, Singapore, Mexico, Brazil, South Africa, UAE, Qatar, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023” in detail along with the table of contents: Based on technology, precision medicine market is segmented into big data analytics, drug discovery, gene sequencing, companion diagnostics, and bioinformatics. Drug discovery based precision medicine market worth USD 9 billion in 2015, is anticipated to grow at a rate of 8.3% over the coming seven years. Gene sequencing based precision medicine industry size worth USD 8 billion in 2015, is expected to witness a substantial growth over the timeframe owing to favorable government policies supporting next-generation sequencing research on people’s genes, lifestyles, and environment. Companion diagnostics based precision medicine market is projected to witness a high surge over the next few years, owing to favorable regulatory norms coupled with high government spending encouraging its use. North American precision medicine market is expected to grow significantly over the coming years due to favorable government regulations. U.S. is predicted to contribute significantly towards the regional share. 2 | P a g e

Asia Pacific precision medicine market is projected to witness a significant surge over the timeframe, owing to growing government investments in healthcare sector & medical research. China is expected to be a major regional revenue contributor. Europe precision medicine industry size worth USD 2.4 billion in 2015, is expected to grow noticeably over 2016-2023, owing to favorable compensation policies. France and Germany are predicted to be the major regional revenue contributors. Market players will try to increase their revenue through product innovations and high R & D investments. Key precision medicine industry participants include Laboratory Genomics of America Holdings, Intomics A/S, Silicon Biosystems, Eagle Genomics Limited, Roche, Covance, Pfizer, and Quest Diagnostics. Segmentation of Precision Medicine Market: Global Market Insights has segmented the precision medicine industry on the basis of technology, application, and region: Precision Medicine Market Technology Analysis (Revenue, USD Million; 2013 - 2023) o Big data analytics o Gene Sequencing o Drug discovery o Bio Informatics o Companion Diagnostics Precision Medicine Market Application Analysis (Revenue, USD Million; 2013 - 2023) o Oncology o CNS o Immunology o Respiratory Precision Medicine Market Regional Analysis (Revenue, USD Million; 2013 - 2023) o North America • U.S. • Canada o Europe • UK • Germany • France • Italy 3 | P a g e

Precision Medicine Market to reach $96 Bn by 2024
U.S. Precision Medicine Market contributed 65% of the North American revenue in 2015
Precision Medicine Market to surpass $96 Bn by 2024